Loading the player...


INFO:
Ruben Mesa, MD, discusses the use of ruxolitinib versus fedratinib in treating patients with myelofibrosis.
Dr. Mesa on Ruxolitinib Vs Fedratinib in Myelofibrosis Treatment | OncLive